+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Regulatory Report: Cyprus CBD

  • ID: 5238388
  • Report
  • December 2020
  • Region: Cyprus
  • 12 Pages
  • CBD Intel
CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place.

The Cypriot legal framework distinguishes between industrial hemp and narcotic cannabis.

In Cyprus, drugs are substances and preparations that are classified by the Law on Drugs and Psychotropic Substances according to their harm in Classes from A to C.
Note: Product cover images may vary from those shown
1 Executive Summary
2 Hemp Plant
3 Extracts as a Finished Product
4 Finished Products Containing CBD and Extracts
5 Import and Export Requirements
6 Medical Cannabis
7 Recreational Cannabis
8 Relevant Laws
9 Relevant Bodies
Note: Product cover images may vary from those shown


General Methodology/Sources

  • Consumer and market participant (manufacturer/brand) surveys.
  • Consolidation of publicly available information.
  • Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
  • Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
  • Findings from key industry events and interviews with leading market players and opinion leaders.
  • Partnerships with leading research agencies.
  • Quantitative and qualitative research and client collaborations.
  • Cross-referenced data between markets.
  • Tamarind Media proprietary market model.

Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.